Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosisMinoru Nakamura, Hiromi Ishibashi, Mutsumi Matsuyama et al.|Hepatology|2006Cited by 365
A Prospective Randomized Trial of the Preventive Effect of Pre‐operative Transcatheter Arterial Embolization against Recurrence of Hepatocellular CarcinomaSusumu Yamasaki, Toshiharu Tsuzuki, Hiroshi Hasegawa et al.|Japanese Journal of Cancer Research|1996Cited by 154